SG Americas Securities LLC Grows Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)

SG Americas Securities LLC lifted its holdings in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 79.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 83,385 shares of the company's stock after acquiring an additional 37,031 shares during the period. SG Americas Securities LLC owned approximately 0.06% of MiMedx Group worth $802,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. Fiduciary Alliance LLC acquired a new stake in MiMedx Group in the 4th quarter worth approximately $160,000. JPMorgan Chase & Co. raised its holdings in shares of MiMedx Group by 265.4% in the third quarter. JPMorgan Chase & Co. now owns 297,367 shares of the company's stock worth $1,757,000 after buying an additional 215,995 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of MiMedx Group by 6.3% during the third quarter. Principal Financial Group Inc. now owns 55,495 shares of the company's stock worth $328,000 after buying an additional 3,292 shares during the period. SkyView Investment Advisors LLC lifted its stake in shares of MiMedx Group by 30.0% during the third quarter. SkyView Investment Advisors LLC now owns 13,000 shares of the company's stock worth $77,000 after buying an additional 3,000 shares during the period. Finally, Barclays PLC grew its holdings in shares of MiMedx Group by 163.9% during the third quarter. Barclays PLC now owns 262,449 shares of the company's stock valued at $1,550,000 after buying an additional 163,005 shares during the last quarter. Institutional investors and hedge funds own 79.15% of the company's stock.

MiMedx Group Stock Performance

Shares of NASDAQ:MDXG traded down $0.14 during midday trading on Thursday, reaching $8.91. The company's stock had a trading volume of 341,078 shares, compared to its average volume of 639,778. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10. The stock has a fifty day moving average of $9.20 and a 200 day moving average of $7.51. MiMedx Group, Inc. has a twelve month low of $5.47 and a twelve month high of $10.14. The firm has a market capitalization of $1.31 billion, a PE ratio of 16.20 and a beta of 1.96.

MiMedx Group (NASDAQ:MDXG - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.02. The company had revenue of $84.06 million for the quarter, compared to the consensus estimate of $81.00 million. MiMedx Group had a return on equity of 26.21% and a net margin of 23.86%. During the same period last year, the firm earned $0.05 EPS. On average, equities analysts expect that MiMedx Group, Inc. will post 0.3 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered MiMedx Group from a "strong-buy" rating to a "buy" rating in a research note on Friday, November 8th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $12.00.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.